USPTO serial 79312278
EGETIS THERAPEUTICS
Reviewed by CopyMark Law Group
Status 401
- Filing date
- Status date
- Registration date
- —
- Examiner
- RINKER, ANTHONY MICHAEL
- Law office
- TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with EGETIS THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical and veterinary preparations and substances, namely, for the treatment of acetaminophen/paracetamol over dose, MCT8 deficiency, RTHb, oncological, neurological, endocrinological, metabolic, hematological, eye, autoimmune and inflammatory related diseases; vaccines; sanitary preparations for medical use; dietetic and nutritional preparations for medical use; diagnostic preparations for medical use; chemical reagents for medical use; diagnostic tests for medical use | SECTION 70 - CANCELLED | — |
| 042 | Medical research; biological and chemical research; research and development of new medicines and medical preparations; medical and chemical laboratories; scientific and industrial research relating to medicinal or veterinary practice; diagnostic and screening services relating to medicinal or veterinary research and development; informational services relating to medicinal or veterinary research and development | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 6, 2022 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Mar 5, 2022 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Dec 19, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 2, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 2, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 2, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 1, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 11, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 7, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 5, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jun 3, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |